TRV GP Iv, LLC, 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 75,000 shares at $11.56 ($867K) on 2024-09-05, disclosed to the SEC on 2024-09-09.
Open-market sale of $867k TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TNGX | SELL | 2025-09-17 | $5.1M | — | Filing → |
| TNGX | SELL | 2025-09-09 | $5.7M | — | Filing → |
| TNGX | SELL | 2024-09-17 | $710K | — | Filing → |